Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
korttidsvirkende insulin |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
humant insulinanalogprodukt |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
langtidsvirkende insulin |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
Product containing insulin lispro (medicinal product) |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pancreatic hormone |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human insulin |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Insulin lispro |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
korttidsvirkende insulin |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
bifasisk insulin lispro |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Insulin lispro protamine (substance) |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
Product containing insulin lispro and insulin lispro protamine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
Insulin lispro-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
bifasisk insulin lispro 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|